834P A phase II study of gemcitabine, cisplatin, and bevacizumab for first recurrent and refractory ovarian clear-cell carcinoma (KCOG-G1601 trial)
| Autor: | Ito, K., Nakagawa, M., Hori, K., Tashima, L., Goto, M., Yanagida, S., Suzuki, J., Kaya, R., Kawabata, A., Park, J., Nasu, H., Nishio, S., Kondo, E., Kaneda, M., Tsubamoto, H., Arakawa, A., Nagasawa, T., Yamada, K. |
|---|---|
| Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S627-S627 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|